Simultaneous determination of azathioprine and 6-mercaptopurine by high-performance liquid chromatography

J Chromatogr B Biomed Appl. 1996 Apr 26;679(1-2):147-54. doi: 10.1016/0378-4347(96)00007-2.

Abstract

A specific, sensitive, single-step solid-phase extraction and reversed-phase high-performance liquid chromatographic method for the simultaneous determination of plasma 6-mercaptopurine and azathioprine concentrations is reported. Following solid-phase extraction, analytes are separated on a C18 column with mobile phase consisting of 0.8% acetonitrile in 1 mM triethylamine, pH 3.2, run on a gradient system. Quantitation limits were 5 ng/ml and 2 ng/ml for azathioprine and 6-mercaptopurine, respectively. Peak heights correlated linearly to known extracted standards for 6-mercaptopurine and azathioprine (r = 0.999) over a range of 2-200 ng/ml. No chromatographic interferences were detected.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Oral
  • Adult
  • Antimetabolites, Antineoplastic / analysis
  • Antimetabolites, Antineoplastic / chemistry
  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Antirheumatic Agents / blood*
  • Antirheumatic Agents / chemistry
  • Antirheumatic Agents / pharmacokinetics
  • Azathioprine / blood*
  • Azathioprine / chemistry
  • Azathioprine / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Drug Stability
  • Female
  • Humans
  • Immunosuppressive Agents / blood*
  • Immunosuppressive Agents / chemistry
  • Immunosuppressive Agents / pharmacokinetics
  • Mercaptopurine / blood*
  • Mercaptopurine / chemistry
  • Mercaptopurine / pharmacokinetics
  • Reproducibility of Results
  • Temperature

Substances

  • Antimetabolites, Antineoplastic
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Mercaptopurine
  • Azathioprine